JAK Signaling in Depression and Cognition in Male Football Players
Emory University · NCT07608796
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 30–55 · Men only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 2
- Target enrollment
- 30
- US sites recruiting
- 3
- Study start
- October 2026
- Record last updated
- September 24, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study is being done to learn more about the role of inflammation in depressive and cognitive symptoms in patients with depression who have played at least 11 years of organized tackle football. This will be evaluated using a medication called baricitinib, which blocks one aspect of inflammation.
Being studied: Baricitinib
Conditions: Depressive Symptoms; Cognitive Symptom
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- willing and able to give written informed consent
- males
- playing tackle football for at least 11 years
- 30-55 years of age
- Current Diagnostic and Statistical Manual (DSM)-V major depression or Bipolar, depressed type; or DSM-V major depression or Bipolar, depressed type in partial remission as diagnosed by the Structured Clinical Interview for the Diagnostic and Statistical Manual for Mental Disorders (SCID)-V
- score of >10 on the PHQ-9 from screening and HAM-D score ≥16 for study entry
- off all antidepressant or other psychotropic therapy (e.g., mood stabilizers, antipsychotics, and sedative hypnotics) for at least 4 weeks before baseline visit (8 weeks for fluoxetine) or on a stable psychotropic regimen for at least 4 weeks (and no planned changes)
- CRP ≥3 mg/L
- PHQ-9 anhedonia (item #1) and cognitive (item #7) scores ≥2
Exclusion Criteria
- current or history of past autoimmune disorder
- history or evidence (clinical or laboratory) of hepatitis B or C infection or human immunodeficiency virus infection
- history of any type of cancer requiring treatment with more than minor surgery
- unstable cardiovascular, endocrinologic, hematologic, hepatic, renal, or neurologic disease (as determined by physical examination, EKG, and laboratory testing)
- significant hematological abnormalities at screening (ANC \< 1500, Hgb\<10, platelet\< 100,000)
- history of progressive multifocal leukoencephalopathy
- history of deep venous thrombosis
- history of cardiovascular disease (coronary artery disease, congestive heart failure, stroke - controlled hypertension is OK)
- major surgery within 6 months before screening, or will require major surgery during the study
- current or recent (\<4 weeks before study start) viral (including COVID-19), bacterial, fungal, or parasitic infection, or any other active or recent infection
- symptomatic herpes zoster infection at or within 12 weeks of study start
- history of disseminated/complicated herpes zoster (for example, ophthalmic zoster or CNS involvement)
- cirrhosis of the liver from any cause
- Additional exclusion criteria apply
Recruiting US locations
Emory Clinic, Emory University Hospital
Atlanta, GA 30322
Site contact: Andrew Miller, MD
Emory School Of Medicine
Atlanta, GA 30322
Emory University
Atlanta, GA 30329
Study contacts (from the official record)
- Andrew H Miller, MD · 404-727-8260 · amill02@emory.edu
Similar studies in Georgia
All mental health studies in Georgia →- RecruitingPhase 1Overnight stay mentioned
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Leal Therapeutics, Inc
- Location
- Decatur, GA + 9 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
BioXcel Therapeutics Inc
- Location
- Decatur, GA + 3 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingHealthy volunteersEarly Phase 1
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
Emory University
- Location
- Atlanta, GA
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteers
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Ecotera Health LLC
- Location
- Atlanta, GA + 50 other US sites
- Eligibility basics
- Ages 18+